Reports
Reports
Sale
The global soft tissue allografts market size was valued at USD 4.82 billion in 2023, driven by the increasing demand for anterior cruciate ligament (ACL) repair among athletes, growing demand for teeth health improvement solutions, and the rapidly rising musculoskeletal issues. The market is anticipated to grow at a CAGR of 7% during the forecast period of 2024-2032 to achieve a value of USD 8.85 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The soft tissue allografts market is driven by an increase in the frequency of orthopaedic surgeries and dental implants.
The soft tissue allografts are referred to as the substitute tissues used to reconstruct deficient ligaments, torn menisci, spinal surgery, and osteochondral defects during knee surgery. They undergo a three-stage safety screening process.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The soft tissue allografts industry is segmented based on types, applications, and end-uses.
Based on types, the industry is divided into:
Based on applications, the industry is segmented into:
Based on end-uses, the industry is divided into:
The EMR report looks into the regional markets of soft tissue allografts like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global soft tissue allografts market is driven by the rising opportunities as the number of procedures rise. The anterior cruciate ligament (ACL) reconstruction has found a common occurrence among sportspersons and is expected to fuel the market growth for soft tissue allografts. The market is further aided by the requirement for healthy teeth to invigorate the demand. The poor lifestyle of the population due to technology addicted lifestyle will provide impetus to the market growth.
The report presents a detailed analysis of the following key players in the global soft tissue allografts market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Applications |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Soft Tissue Allografts Market Overview
3.1 Global Soft Tissue Allografts Market Historical Value (2017-2023)
3.2 Global Soft Tissue Allografts Market Forecast Value (2024-2032)
4 Global Soft Tissue Allografts Market Landscape
4.1 Global Soft Tissue Allografts Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Soft Tissue Allografts Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Soft Tissue Allografts Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Soft Tissue Allografts Market Segmentation
6.1 Global Soft Tissue Allografts Market by Type
6.1.1 Market Overview
6.1.2 Cartilage Allografts
6.1.3 Hyaline Cartilage
6.1.4 Elastic Cartilage
6.1.5 Fibro Cartilage
6.1.6 Tendon Allografts
6.1.7 Achilles Tendon
6.1.8 Tibialis
6.1.9 Patellar Tendon
6.1.10 Hamstring
6.1.11 Meniscus Allografts
6.1.12 Dental Allografts
6.1.13 Free Gingival Graft
6.1.14 Connective Tissue Graft
6.1.15 Pedicle Graft
6.1.16 Collagen Allografts
6.1.17 Amniotic Allografts
6.2 Global Soft Tissue Allografts Market by Applications
6.2.1 Market Overview
6.2.2 Orthopedic
6.2.3 Sports Medicine
6.2.4 Spine Surgeries
6.2.5 General Orthopedic
6.2.6 Reconstruction
6.2.7 Dentistry
6.2.8 Dental Sensitivity
6.2.9 Aesthetics
6.2.10 Wound Care
6.2.11 Others
6.3 Global Soft Tissue Allografts Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Orthopedic Clinics
6.3.4 Dental Clinics
6.3.5 Aesthetic Centers
6.3.6 Others
6.4 Global Soft Tissue Allografts Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Soft Tissue Allografts Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Soft Tissue Allografts Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Soft Tissue Allografts Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Soft Tissue Allografts Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Soft Tissue Allografts Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 CONMED Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 XTANT MEDICAL
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 ALONSOURCE GROUP
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 BD
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Arthrex, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Bone Bank Allografts
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Integra LifeSciences
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Stryker
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 RTI Surgical
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 AlloSource
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Soft Tissue Allografts Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2023, the market for soft tissue allografts attained a value of USD 4.82 billion.
The market is anticipated to grow at a CAGR of 7% during the forecast period of 2024-2032 to reach a value of USD 8.85 billion by 2032.
The market is being driven by the increased demand for anterior cruciate ligament (ACL) repair among athletes, growing demand for teeth health improvement solutions, rising musculoskeletal issues, and the sedentary lifestyle.
The key trends propelling the industry growth include the rising demand for orthopaedic procedures and dental implants.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The significant types include cartilage allograft, tendon allograft, meniscus allograft, dental allograft, and others.
The major applications include orthopaedic, dentistry, wound care, and others.
The different end uses include hospitals, aesthetic centres, orthopaedic clinics, dental clinics, and others.
The major players in the industry are Allergan [AGN (NYSE)], CONMED Corporation [CNMD (NASDAQ)], Xtant Medical [CNMD (NASDAQ)], Becton, Dickinson and Company [BDX (NYSE)], and others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.